{"transactions":[{"id":741423,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:25:40.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":4977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":4977,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":4977},"source":{"system":"sec-edgar","filing":"0001193125-26-267623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000119312526267623/ownership.xml","form_type":"4"}},{"id":741422,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:25:40.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":6636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":6636,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":6636},"source":{"system":"sec-edgar","filing":"0001193125-26-267623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000119312526267623/ownership.xml","form_type":"4"}},{"id":741421,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:25:40.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":70000,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001193125-26-267623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000119312526267623/ownership.xml","form_type":"4"}},{"id":1113071,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:21:47.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":3619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":3619,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":3619},"source":{"system":"sec-edgar","filing":"0000950170-25-085419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017025085419/ownership.xml","form_type":"4"}},{"id":1113070,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:21:47.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":4825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":4825,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":4825},"source":{"system":"sec-edgar","filing":"0000950170-25-085419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017025085419/ownership.xml","form_type":"4"}},{"id":1113069,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:21:47.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":62728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":62728,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":62728},"source":{"system":"sec-edgar","filing":"0000950170-25-085419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017025085419/ownership.xml","form_type":"4"}},{"id":1488185,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:06:46.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":2604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2604,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":2604},"source":{"system":"sec-edgar","filing":"0000950170-24-069874","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017024069874/ownership.xml","form_type":"4"}},{"id":1488184,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:06:46.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":3473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":3473,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":3473},"source":{"system":"sec-edgar","filing":"0000950170-24-069874","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017024069874/ownership.xml","form_type":"4"}},{"id":1488183,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:06:46.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":40282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":40282,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":40282},"source":{"system":"sec-edgar","filing":"0000950170-24-069874","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017024069874/ownership.xml","form_type":"4"}},{"id":1783778,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-11T20:31:41.000Z","date":"2023-09-07","kind":"exercise","planned":false,"acquired":false,"shares":5437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.552,"expiration_date":"2023-09-07","underlying":"Common Stock","underlying_shares":5437},"source":{"system":"sec-edgar","filing":"0000950170-23-047497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017023047497/ownership.xml","form_type":"4"}},{"id":1783777,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-11T20:31:41.000Z","date":"2023-09-07","kind":"exercise","planned":false,"acquired":true,"shares":5437,"price":0.552,"value":3001.224,"ownership":{"direct":true},"balance_after":14812,"source":{"system":"sec-edgar","filing":"0000950170-23-047497","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017023047497/ownership.xml","form_type":"4"}},{"id":1835488,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T21:43:50.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":1372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1372,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":1372},"source":{"system":"sec-edgar","filing":"0000950170-23-031788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017023031788/ownership.xml","form_type":"4"}},{"id":1835487,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T21:43:50.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":1829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1829,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":1829},"source":{"system":"sec-edgar","filing":"0000950170-23-031788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017023031788/ownership.xml","form_type":"4"}},{"id":1835486,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T21:43:50.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":21222,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":21222},"source":{"system":"sec-edgar","filing":"0000950170-23-031788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095017023031788/ownership.xml","form_type":"4"}},{"id":2237474,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:06:13.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":3479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":3479,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":3479},"source":{"system":"sec-edgar","filing":"0000899243-22-021634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924322021634/doc4.xml","form_type":"4"}},{"id":2237473,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:06:13.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":4639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":4639,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":4639},"source":{"system":"sec-edgar","filing":"0000899243-22-021634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924322021634/doc4.xml","form_type":"4"}},{"id":2237472,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:06:13.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":53812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":53812,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":53812},"source":{"system":"sec-edgar","filing":"0000899243-22-021634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924322021634/doc4.xml","form_type":"4"}},{"id":2673619,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T21:46:48.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":875,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":875},"source":{"system":"sec-edgar","filing":"0000899243-21-023012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924321023012/doc4.xml","form_type":"4"}},{"id":2673618,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T21:46:48.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":1167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1167,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":1167},"source":{"system":"sec-edgar","filing":"0000899243-21-023012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924321023012/doc4.xml","form_type":"4"}},{"id":2673617,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T21:46:48.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":13534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":13534,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":13534},"source":{"system":"sec-edgar","filing":"0000899243-21-023012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924321023012/doc4.xml","form_type":"4"}},{"id":3113115,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T21:45:38.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":3082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":3082,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":3082},"source":{"system":"sec-edgar","filing":"0000899243-20-016177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924320016177/doc4.xml","form_type":"4"}},{"id":3113114,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T21:45:38.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":26503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":26503,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":26503},"source":{"system":"sec-edgar","filing":"0000899243-20-016177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924320016177/doc4.xml","form_type":"4"}},{"id":3138836,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T20:31:45.000Z","date":"2020-05-20","kind":"disposition_to_issuer","acquired":false,"shares":33620,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common stock and derivative securities of Zyla Life Sciences (\"Issuer\") were disposed of pursuant to the Agreement and Plan of Merger, dated as of March 16, 2020 (the \"Merger Agreement\"), by and among Issuer, Assertio Holdings, Inc. (\"Parent\"), Assertio Therapeutics, Inc., Alligator Merger Sub, Inc. and Zyla Merger Sub, Inc. (\"Merger Sub\"), pursuant to which each share of the Issuer's common stock issued and outstanding immediately prior to the effective time of the merger of Merger Sub with and into Issuer (the \"Effective Time\") was converted into the right to receive, and became exchangeable for, (1) 2.5 shares of Parent common stock for each share of Issuer's common stock and (2) any cash in lieu of fractional shares of Parent common stock.  Parent common stock had a market value of approximately $0.80 per share at the close of market immediately prior to the Effective Time"},{"field":"kind","element":"transactionCoding","label":"F2","text":". Includes unvested time-based restricted stock units representing a contingent right to receive 33,620 shares of Issuer common stock upon vesting and settlement of such time-based restricted stock units.  At the Effective Time, all outstanding time-based restricted stock units of Issuer were cancelled and, in exchange therefor, each former holder of any such cancelled restricted stock unit has the right to receive a number of shares of fully vested Parent common stock (rounded to the nearest whole number) equal to the product of (1) 2.5 and (2) the number of shares of Issuer common stock covered by such restricted stock unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock and derivative securities of Zyla Life Sciences (\"Issuer\") were disposed of pursuant to the Agreement and Plan of Merger, dated as of March 16, 2020 (the \"Merger Agreement\"), by and among Issuer, Assertio Holdings, Inc. (\"Parent\"), Assertio Therapeutics, Inc., Alligator Merger Sub, Inc. and Zyla Merger Sub, Inc. (\"Merger Sub\"), pursuant to which each share of the Issuer's common stock issued and outstanding immediately prior to the effective time of the merger of Merger Sub with and into Issuer (the \"Effective Time\") was converted into the right to receive, and became exchangeable for, (1) 2.5 shares of Parent common stock for each share of Issuer's common stock and (2) any cash in lieu of fractional shares of Parent common stock.  Parent common stock had a market value of approximately $0.80 per share at the close of market immediately prior to the Effective Time"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":". Includes unvested time-based restricted stock units representing a contingent right to receive 33,620 shares of Issuer common stock upon vesting and settlement of such time-based restricted stock units.  At the Effective Time, all outstanding time-based restricted stock units of Issuer were cancelled and, in exchange therefor, each former holder of any such cancelled restricted stock unit has the right to receive a number of shares of fully vested Parent common stock (rounded to the nearest whole number) equal to the product of (1) 2.5 and (2) the number of shares of Issuer common stock covered by such restricted stock unit."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-064792","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000110465920064792/a4.xml","form_type":"4"}},{"id":3224279,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-06T01:40:00.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":13620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, which vest the day prior to the Company's annual meeting of stockholders to be held in 2021."}],"balance_after":13620,"source":{"system":"sec-edgar","filing":"0001179110-20-003200","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000117911020003200/edgar.xml","form_type":"4"}},{"id":3482274,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-20T20:08:50.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, which vest in three equal annual installments on the first three anniversaries of the date of grant."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001179110-19-007932","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000117911019007932/edgar.xml","form_type":"4"}},{"id":3498579,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T21:36:32.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":2204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2204,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":2204},"source":{"system":"sec-edgar","filing":"0000899243-19-015822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924319015822/doc4.xml","form_type":"4"}},{"id":3498578,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T21:36:32.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":18951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":18951,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":18951},"source":{"system":"sec-edgar","filing":"0000899243-19-015822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924319015822/doc4.xml","form_type":"4"}},{"id":3899717,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T20:35:53.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":1805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation  Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1805,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":1805},"source":{"system":"sec-edgar","filing":"0000899243-18-015767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924318015767/doc4.xml","form_type":"4"}},{"id":3899716,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T20:35:53.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":15526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":15526,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":15526},"source":{"system":"sec-edgar","filing":"0000899243-18-015767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924318015767/doc4.xml","form_type":"4"}},{"id":4105240,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Chief Strategy Ofcr"}}],"security":"Ordinary Shares","published_at":"2018-01-06T00:25:13.000Z","date":"2018-01-04","kind":"tax_withholding","acquired":false,"shares":463,"price":23.4,"value":10834.2,"ownership":{"direct":true},"balance_after":21178,"source":{"system":"sec-edgar","filing":"0000950138-18-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095013818000041/edgar.xml","form_type":"4"}},{"id":4105239,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Chief Strategy Ofcr"}}],"security":"Ordinary Shares","published_at":"2018-01-06T00:25:13.000Z","date":"2018-01-03","kind":"tax_withholding","acquired":false,"shares":834,"price":23.51,"value":19607.34,"ownership":{"direct":true},"balance_after":21641,"source":{"system":"sec-edgar","filing":"0000950138-18-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095013818000041/edgar.xml","form_type":"4"}},{"id":4107042,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Chief Strategy Ofcr"}}],"security":"Ordinary Shares","published_at":"2018-01-05T00:24:34.000Z","date":"2018-01-02","kind":"tax_withholding","acquired":false,"shares":1687,"price":23.52,"value":39678.24,"ownership":{"direct":true},"balance_after":22475,"source":{"system":"sec-edgar","filing":"0000950138-18-000030","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095013818000030/edgar.xml","form_type":"4"}},{"id":4107041,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Chief Strategy Ofcr"}}],"security":"Ordinary Shares","published_at":"2018-01-05T00:24:34.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":1540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of performance share award granted on January 2, 2015."}],"balance_after":24162,"source":{"system":"sec-edgar","filing":"0000950138-18-000030","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095013818000030/edgar.xml","form_type":"4"}},{"id":4275187,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-21T20:06:46.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan.  The option shall vest in equal quarterly installments at the end of each quarter following June 20, 2017 subject to continued service through such dates."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-17-016836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924317016836/doc4.xml","form_type":"4"}},{"id":4285301,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T21:05:29.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":2963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation  Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2963,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":2963},"source":{"system":"sec-edgar","filing":"0000899243-17-016101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924317016101/doc4.xml","form_type":"4"}},{"id":4285300,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T21:05:29.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":17776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":17776,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":17776},"source":{"system":"sec-edgar","filing":"0000899243-17-016101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000089924317016101/doc4.xml","form_type":"4"}},{"id":4496183,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Chief Strategy Ofcr"}}],"security":"Ordinary Shares","published_at":"2017-01-06T23:00:45.000Z","date":"2017-01-04","kind":"tax_withholding","acquired":false,"shares":347,"price":53.19,"value":18456.93,"ownership":{"direct":true},"balance_after":22622,"source":{"system":"sec-edgar","filing":"0000950138-17-000043","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095013817000043/edgar.xml","form_type":"4"}},{"id":4501995,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Chief Strategy Ofcr"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2017-01-05T02:08:40.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":36925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in their entirety on January 3, 2021."}],"balance_after":36925,"derivative":{"exercise_price":51.73,"exercise_date":"2021-01-03","expiration_date":"2027-01-03","underlying":"Ordinary Shares","underlying_shares":36925},"source":{"system":"sec-edgar","filing":"0000950138-17-000021","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095013817000021/edgar.xml","form_type":"4"}},{"id":4501994,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Chief Strategy Ofcr"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2017-01-05T02:08:40.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":43441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in four equal annual installments beginning January 3, 2018."}],"balance_after":43441,"derivative":{"exercise_price":51.73,"exercise_date":"2018-01-03","expiration_date":"2027-01-03","underlying":"Ordinary Shares","underlying_shares":43441},"source":{"system":"sec-edgar","filing":"0000950138-17-000021","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095013817000021/edgar.xml","form_type":"4"}},{"id":4501993,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Chief Strategy Ofcr"}}],"security":"Ordinary Shares","published_at":"2017-01-05T02:08:40.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":7733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that vest in four equal annual installments beginning January 3, 2018."}],"balance_after":22969,"source":{"system":"sec-edgar","filing":"0000950138-17-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095013817000021/edgar.xml","form_type":"4"}},{"id":4501992,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Chief Strategy Ofcr"}}],"security":"Ordinary Shares","published_at":"2017-01-05T02:08:40.000Z","date":"2017-01-02","kind":"tax_withholding","acquired":false,"shares":3073,"price":49.82,"value":153096.86,"ownership":{"direct":true},"balance_after":15236,"source":{"system":"sec-edgar","filing":"0000950138-17-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095013817000021/edgar.xml","form_type":"4"}},{"id":4501991,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":39205,"kind":"person","name":"Phillips Gary M.","position":1,"cik":"0001197795","reported_name":"Phillips Gary M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Chief Strategy Ofcr"}}],"security":"Ordinary Shares","published_at":"2017-01-05T02:08:40.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":6732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of performance share award granted on January 2, 2014."}],"balance_after":18309,"source":{"system":"sec-edgar","filing":"0000950138-17-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197795/000095013817000021/edgar.xml","form_type":"4"}}]}